217343 An Overview of WHO's Global Alcohol Control Strategy: Background advocacy, rationale and update on action

Tuesday, November 9, 2010 : 8:30 AM - 8:45 AM

Donald W. Zeigler, PhD , Long Range Health Care Trends, Amercian Medical Association, Chicago, IL
There is mounting evidence of the magnitude of the global burden of disease linked to alcohol use and abuse. Heretofore, the World Health Organization (WHO) has given relatively little attention to alcohol control, particularly compared to its work on addressing tobacco through development of the Framework Convention on Tobacco Control. However, recent advocacy has prompted the WHO to consider and adopt a comprehensive alcohol strategy. The presentation will discuss advocacy efforts and provide an overview of the WHO strategy and suggest options and implications for global alcohol control.

Learning Areas:
Administer health education strategies, interventions and programs
Advocacy for health and health education
Chronic disease management and prevention
Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Public health or related public policy

Learning Objectives:
1. Recognize the components of successful advocacy by nongovernmental and governmental groups to advance global alcohol control leading up to action by the World Health Organization; 2. Describe the rationale and details of the WHO alcohol strategy; and 3. Identify potential implications and challenges implementing the strategy with specific examples in the Russian Federation.

Keywords: Alcohol Problems, International Health

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am in the leadership of the ATOD section and have worked at the American Medical Association on alcohol control interventions at the national and state levels and policy at the local, state, national and international levels.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.